Press release
2024 Global Crohn's Disease Treatment Market Size, Share, Trends And Growth Analysis Report | AbbVie Inc., AstraZeneca plc, Boehringer Ingelheim GmbH, Celgene Corporation, Eli Lilly and Company
Crohn's Disease Treatment Global Market Report 2024
Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=10852&type=smp
Rising Tide Of Inflammatory Bowel Disorders Drives Crohn'S Disease Treatment Market
The increase in the prevalence of inflammatory bowel disorders is expected to propel the growth of the Crohn's disease treatment market going forward. Inflammatory bowel disorders refer to a group of chronic conditions involving gastrointestinal tract inflammation. It can cause inflammation and damage to any part of the digestive system, from the mouth to the anus. Crohn's disease helps by decreasing the inflammation of the intestine, to prevent flare-ups of symptoms, and to keep in remission. For instance, in April 2020, according to a survey by the American Gastroenterological Association covering 33 countries on six continents regarding the prevalence of and factors associated with functional gastrointestinal disorders, among the 73,076 adult respondents, more than 40% of persons worldwide have Functional gastrointestinal disorders (FGIDs), which affect the quality of life and health care use. Therefore, the increase in the prevalence of inflammatory bowel disorders is driving the growth of the Crohn's disease treatment market.
Product Innovation Propels Crohn's Disease Treatment To New Heights
Product innovation is the key trend gaining popularity in the Crohn's disease treatment market. Major companies operating in the Crohn's disease treatment sector are focused on developing innovative products to strengthen their position in the market. For instance, in May 2023, AbbVie Inc., a US-based pharmaceutical company, received Rinvoq (upadacitinib) approval from U.S. Food and Drug Administration (FDA). Rinvoq is indicated for treating moderate to highly active Crohn's disease. Rinvoq's efficacy and safety were assessed in two randomized induction studies, CD-1 (NCT03345836) and CD-2 (NCT03345849), involving 857 patients with moderately to highly active Crohn's disease.
The crohn's disease treatment market covered in this report is segmented -
1) By Drug Type: Antibiotics, Amino Salicylates, Corticosteroids, Immunomodulators, Other Drug Types
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
3) By Application: Neuropathic Pain, Fibromyalgia, Chronic Back Pain, Arthritic Pain, Migraine Post-Operative Pain, Cancer Pain, Other Applications
Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=10852&type=discount
Major companies operating in the crohn's disease treatment market report are AbbVie Inc., AstraZeneca plc, Boehringer Ingelheim GmbH, Celgene Corporation, Eli Lilly and Company, Janssen Pharmaceuticals, Pfizer Inc., Takeda Pharmaceutical Company Limited, Biogen Inc., Bristol-Myers Squibb Company, Galapagos NV, Gilead Sciences Inc., Novartis AG, Sanofi S.A., Union Chimique Belge, Astellas Pharma Inc., F. Hoffmann-La Roche Ltd., Vertex Pharmaceuticals Incorporated, Teva Pharmaceutical Industries Ltd., Merck & Co. Inc., Regeneron Pharmaceuticals Inc., Mylan N.V., Glenmark Pharmaceuticals, Tillotts Pharma AG, Dr. Falk Pharma GmbH, Shire Pharmaceuticals, Salix Pharmaceuticals, Prometheus Laboratories Inc., Arena Pharmaceuticals Inc.
Contents of the report:
1. Executive Summary
2. Crohn's Disease Treatment Market Report Structure
3. Crohn's Disease Treatment Market Trends And Strategies
4. Crohn's Disease Treatment Market - Macro Economic Scenario
5. Crohn's Disease Treatment Market Size And Growth
…..
27. Crohn's Disease Treatment Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/crohns-disease-treatment-global-market-report
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ "
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release 2024 Global Crohn's Disease Treatment Market Size, Share, Trends And Growth Analysis Report | AbbVie Inc., AstraZeneca plc, Boehringer Ingelheim GmbH, Celgene Corporation, Eli Lilly and Company here
News-ID: 3595990 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Crohn
Global IBD Ulcerative Colitis And Crohn S Disease Treatment Industry Poised for …
The IBD Ulcerative Colitis And Crohn S Disease Treatment Market research report offers crucial insights into how the industry is evolving, highlighting key drivers of growth and the main revenue streams expected between 2024 and 2032. Similar to a compass, it helps businesses navigate the market's complexities by showcasing both the present situation and the newest developments influencing its direction. For businesses, stakeholders, and industry participants, this report serves as…
Global Companion Animal Specialty Drugs and Crohn s Disease Drug (COVID-19 Imapa …
The Companion Animal Specialty Drugs Market ( https://bit.ly/31KDIZZ ) report is intended to function as a supportive means to assess the Companion Animal Specialty Drugs market along with the complete analysis and clear-cut statistics related to this market. In other words, the report would provide an up-to-date study of the market in terms of its latest trends, present scenario, and the overall market situation. Further, it will also help the…
Crohn’s Disease Drugs Market Research and Clinical Analysis 2020 - Bayer AG, Amg …
The Crohn's Disease Drugs Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Order a Copy of…
Crohn s Disease Drug Market to Witness Huge Growth by 2025 | AbbVie, Janssen Bio …
HTF MI recently introduced Global Crohn s Disease Drug Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are AbbVie, Janssen Biotech, UCB, Amgen, Tillotts Pharma & Takeda…
Crohn Disease Market 2018 by its Scientific Reviews, Clinical Application and Ke …
Global Crohn Disease Market Professional Survey Report 2018 to 2025 presents an in-depth assessment of the Crohn Disease Market including enabling key trends, market drivers, challenges, standardization, regulatory landscape, deployment models, operator case studies, opportunities, future roadmap, value chain, ecosystem player profiles and strategies. The report also presents forecasts for Crohn Disease Market investments from 2018 till 2025.
This study answers several questions for stakeholders, primarily which market segments…
Crohn Disease Market Set for Expansive Growth by 2022
This report studies the global Crohn Disease market, analyzes and researches the Crohn Disease development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
Johnson & Johnson
Pfizer
Sanofi
Merck
GSK
AbbVie
Takeda
Ferring
UCB
Boehringer Ingelheim
Ask for sample copy @ http://www.researchtrades.com/request-sample/1117798
Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia
Market segment by Type, Crohn Disease can be split into
Small Intestine and Ileocephalitis
Colon Disease
Market segment…
